ArticleFrontiers in neurology2026
In-hospital outcomes and documented 90-day readmission to the index hospital in older patients with Parkinson's disease hospitalised for lower respiratory tract infection: a single-centre retrospective cohort study.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lower respiratory tract infection (LRTI) is a major cause of hospitalisation in older adults with Parkinson's disease (PD), but it remains uncertain whether PD-related measures provide clinically relevant information beyond general vulnerability and acute infection severity. Methods: We conducted a single-centre retrospective cohort study of patients aged ≥65 years with neurologist-diagnosed PD who were hospitalised for LRTI between 2018 and 2025. The primary outcome was a composite of intensive care unit admission, invasive mechanical ventilation, or in-hospital death. Documented readmission to the index hospital within 90 days among survivors was analysed as a secondary exploratory outcome. Multivariable logistic and Cox regression models evaluated clinical factors associated with these outcomes. A hierarchical extension added Hoehn-Yahr stage and pre-admission wheelchair- or bed-bound status to the base clinical model. Calendar-period analyses and bootstrap internal validation were performed. Results: Among 246 patients, 62 (25.2%) experienced the composite in-hospital outcome. In the PD-specific extended model, higher Charlson Comorbidity Index (adjusted odds ratio [OR] per 1-point increase 1.19, 95% confidence interval [CI] 1.00-1.42), hypoxaemia (OR 2.00, 95% CI 1.01-3.96), serum albumin <35 g/L (OR 3.18, 95% CI 1.65-6.14), sepsis or septic shock (OR 2.41, 95% CI 1.17-4.98), and pre-admission wheelchair- or bed-bound status (OR 2.08, 95% CI 1.08-4.01) were associated with the outcome. Hoehn-Yahr stage, PD duration, tube feeding, and antiparkinsonian medication burden were not independently associated. Among 228 patients discharged alive, 74 (32.5%) had a documented readmission to the index hospital. Hypoalbuminaemia (adjusted hazard ratio [HR] 1.82, 95% CI 1.12-2.95) and non-home discharge (HR 1.96, 95% CI 1.19-3.24) were among the factors associated with documented same-hospital return. Bootstrap-corrected discrimination was 0.81 for the extended logistic model and 0.70 for the Cox model. Conclusion: Severe in-hospital deterioration was associated mainly with general physiological vulnerability, acute infection severity, and pre-admission mobility dependence, whereas most other available PD-specific measures showed no clear independent association. These findings support integrated clinical assessment but not a validated PD-specific prediction strategy; the post-discharge analysis reflects documented return to the index hospital rather than complete population-level readmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.